“…It was found that by overexpressing miR-101 and miR-139 ( Figure 6D ) can downregulate rock1 while causing PI3K/AKT and JAK/STAT signaling pathway inactivation, ultimately leading to the malignant behavior of osteosarcoma cells can be partially suppressed, including biological behaviors such as abnormal proliferation, migration and invasion ( 191 , 197 ). MiR-340-5p ( 165 ), miR-506-3p ( 159 ), miR-615 ( 59 ), miR-18a ( 192 ), miR-122-5p ( 193 ), miR-451a ( 26 ), miR-449a ( 172 ), miR-142 ( 199 ), miR-499a-5p ( 175 ), miR-6888-3p ( 202 ), miR-384 ( 203 ), and miR-223 ( 205 ), miR-29c-3p ( 178 ), miR-152 ( 207 ), miR-149-5p ( 180 ), miR-652 ( 212 ), miR-1224-5p ( 213 ), miR-146b-5p ( 204 ), miR-141-3p ( 209 ), miR-141 [198], miR-29b ( 187 ), and miR-223 ( 188 ) are all lowly expressed in osteosarcoma cells as tumor suppressors, and they can act directly on NRF2, RAB3D, HK2, MED27, TP53, YTHDC1, EZH2, CDK6, PPM1D, SYK, SLBP, Hsp90B1, TPX2, c-MET, Fn14, HOXA9, PLK1, PDK1, SIX1, AUF1, Spin 1, Ect2 and thus inhibit the PI3K/AKT pathway, which ultimately leads to the impact of osteosarcoma cells in proliferation, migration, invasion, apoptosis, autophagy, cell cycle, cell growth, etc., and inhibits the development of osteosarcoma and progression of osteosarcoma. In addition, miR-206 can also act on both PAX3 and MET target genes to achieve the inhibition of PI3K/AKT pathway through two pathways, so the inhibitory effect of miR-206 on osteosarcoma may be more obvious ( Figure 6E ) ( 189 ).…”